SCHEMBL2295800

SCHEMBL2295800

CCCC(CCC)c1cc(O)c(-c2c(O)cc(C(CCC)CCC)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
TP53 P04637 2/20 0.44
ALDH1A1 P00352 4/20 0.38
CYP1A2 P05177 3/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ATP2A2 P16615 1/20 0.38
ATP2A3 Q93084 1/20 0.38
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
GAA P10253 1/20 0.33
XBP1 P17861 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TYR P14679 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2293474 0.94 ALOX15 (0.40) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL2291030 0.93 ALOX15 (0.42) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL2292908 0.84 NPSR1 (0.41) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL15065029 0.79 CYP2C9 (0.41) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL2293692 0.79 GAA (0.39) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL2289500 0.78 KDR (0.37) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL2290751 0.76 KDR (0.39) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL27607951 0.76 CA2 (0.40) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL15065448 0.74 CYP2C9 (0.37) ALOX15CYP2C9CYP2D6CYP2C19TP53
SCHEMBL17781754 0.73 CYP2C9 (0.39) ALOX15CYP2C9CYP2D6CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346887-B1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES DOW TECHNOLOGY INVESTMENTS LLC (US) 2013-12-25 EP disclosed
US-8546600-B2 Slurry process for synthesis of bisphosphites and situ use thereof for producing bisphosphite DOW TECHNOLOGY INVESTMENTS LLC 2013-10-01 US disclosed
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE DOW TECHNOLOGY INVESTMENTS LLC 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196166-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES AND SITU USE THEREOF FOR PRODUCING BISPHOSPHITE SOST, PLCB3, PPIP5K2 ALOX15 2202/4885CYP2C9 1721/4885CYP2D6 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.